TheraLight Inc., a privately held developer of light-based medical instruments, said on
Tuesday that it received clearance from the US Food and Drug Administration (FDA) to market its UV120-2 UVA/UVB phototherapy system for the treatment of psoriasis, vitiligo, and atopic and seborrheic dermatitis.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!